Xu Dan Dan, Leong Merrin Man Long, Wong Fuk-Ling, Lam Hon Ming, Hoeven Robin
Shandong University of Traditional Chinese Medicine, Jinan, China.
Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Microbiology, Harvard Medical School, Boston, MA, 02115, USA.
Photodiagnosis Photodyn Ther. 2020 Sep;31:101933. doi: 10.1016/j.pdpdt.2020.101933. Epub 2020 Jul 24.
Photodynamic therapy for prostate cancer has emerged, however the evaluation of its mechanism of action has not yet been clarified. This study aims to explore the mechanism and significance of photodynamic therapy on prostate cancer in vitro.
Cultured prostate cancer cells were divided into two groups: untreated and photodynamic therapy treatment. The protein of each group was extracted and analyzed by MALDI-TOF/MSMS method. The significantly expressed proteins were identified in the NCBI human protein database. The change of mitochondrial membrane permeability after photodynamic treatment was examined by transmission electron microscopy.
The total protein content and band distribution of photodynamic treatment group were similar to the control group. Two mitochondrial membrane proteins were down-regulated significantly. They are mitochondrial heat shock protein (HSP60) (Entrez Gene ID: 31542947, PI 5.7, MW: 61016.4, Protein Score: 354, Protein Score C.I.%:100), and voltage-dependent anion channel (VDAC) (Entrez Gene ID: 340201, PI 7.49, MW: 31574.6, Protein Score: 178, Protein Score C.I.%:100). Transmission electron microscopy showed the loss of integrity of mitochondrial membranes.
Photodynamic therapy changes mitochondrial membrane permeability, leading to the eventual death of cancer cells. The regulation of proteins related to mitochondrial membrane permeability may become an indicator of the efficacy of photodynamic therapy.
前列腺癌的光动力疗法已出现,但对其作用机制的评估尚未阐明。本研究旨在探讨光动力疗法在体外对前列腺癌作用的机制及意义。
将培养的前列腺癌细胞分为两组:未处理组和光动力疗法处理组。提取每组细胞的蛋白质,采用基质辅助激光解吸电离飞行时间串联质谱法(MALDI-TOF/MSMS)进行分析。在NCBI人类蛋白质数据库中鉴定显著表达的蛋白质。通过透射电子显微镜检查光动力处理后线粒体膜通透性的变化。
光动力处理组的总蛋白含量和条带分布与对照组相似。两种线粒体膜蛋白显著下调。它们是线粒体热休克蛋白(HSP60)(Entrez基因ID:31542947,等电点5.7,分子量:61016.4,蛋白得分:354,蛋白得分置信区间%:100)和电压依赖性阴离子通道(VDAC)(Entrez基因ID:340201,等电点7.49,分子量:31574.6,蛋白得分:178,蛋白得分置信区间%:100)。透射电子显微镜显示线粒体膜完整性丧失。
光动力疗法改变线粒体膜通透性,导致癌细胞最终死亡。与线粒体膜通透性相关的蛋白质调节可能成为光动力疗法疗效的一个指标。